BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 32690020)

  • 1. Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies.
    Hou HA; Tien HF
    J Biomed Sci; 2020 Jul; 27(1):81. PubMed ID: 32690020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in AML: prognostic and therapeutic implications.
    DiNardo CD; Cortes JE
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):348-355. PubMed ID: 27913501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions.
    DiNardo C; Lachowiez C
    Curr Hematol Malig Rep; 2019 Oct; 14(5):386-394. PubMed ID: 31350639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy-number analysis identified new prognostic marker in acute myeloid leukemia.
    Nibourel O; Guihard S; Roumier C; Pottier N; Terre C; Paquet A; Peyrouze P; Geffroy S; Quentin S; Alberdi A; Abdelali RB; Renneville A; Demay C; Celli-Lebras K; Barbry P; Quesnel B; Castaigne S; Dombret H; Soulier J; Preudhomme C; Cheok MH
    Leukemia; 2017 Mar; 31(3):555-564. PubMed ID: 27686867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?
    Madanat YF; Kalaycio ME; Nazha A
    Acta Med Acad; 2019 Apr; 48(1):35-44. PubMed ID: 31264431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of molecular markers in acute myeloid leukemia.
    Kayser S; Levis MJ
    Eur J Haematol; 2019 Jan; 102(1):20-35. PubMed ID: 30203623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stratified treatment of fit and unfit acute myeloid leukemia].
    Yoshimoto G
    Rinsho Ketsueki; 2021; 62(8):967-977. PubMed ID: 34497237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
    Yang F; Anekpuritanang T; Press RD
    Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Evolving AML Genomic Landscape: Therapeutic Implications.
    Horibata S; Alyateem G; DeStefano CB; Gottesman MM
    Curr Cancer Drug Targets; 2020; 20(7):532-544. PubMed ID: 32329691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic aberrations and new treatment strategies for pediatric acute myeloid leukemia].
    Shiba N
    Rinsho Ketsueki; 2018; 59(10):2260-2267. PubMed ID: 30305534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.
    Bret C; Viziteu E; Kassambara A; Moreaux J
    Expert Rev Hematol; 2016; 9(4):351-60. PubMed ID: 26761438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia.
    Long L; Assaraf YG; Lei ZN; Peng H; Yang L; Chen ZS; Ren S
    Drug Resist Updat; 2020 Sep; 52():100703. PubMed ID: 32599434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
    Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
    J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways.
    Bullinger L; Döhner K; Döhner H
    J Clin Oncol; 2017 Mar; 35(9):934-946. PubMed ID: 28297624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute myeloid leukemia. Genetic diagnostics and molecular therapy].
    Schlenk RF; Döhner K; Döhner H
    Internist (Berl); 2013 Feb; 54(2):171-8. PubMed ID: 23358744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genomics of acute myeloid leukemia in children.
    Conneely SE; Rau RE
    Cancer Metastasis Rev; 2020 Mar; 39(1):189-209. PubMed ID: 31925603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncommon cytogenetic abnormalities identifying high-risk acute myeloid leukemia in children.
    Masetti R; Bertuccio SN; Guidi V; Cerasi S; Lonetti A; Pession A
    Future Oncol; 2020 Nov; 16(33):2747-2762. PubMed ID: 32813587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?
    Patel JP; Levine RL
    Hematology Am Soc Hematol Educ Program; 2012; 2012():28-34. PubMed ID: 23233557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Precision medicine for acute myeloid leukemia based on genomic profiling].
    Sanada M
    Rinsho Ketsueki; 2019; 60(7):847-853. PubMed ID: 31391376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.